genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Gamida-Cell
Drug Discovery
StockWatch: Analysts Mixed on Moderna Despite $750M Financing, Vaccine Updates
Cancer
StockWatch: J&J Falls and Rises on Q1 Results, Leaked Data, Trial Halt
GEN Edge
StockWatch: COPD Data, Analysts, Treg Cell Therapy Deal Lift Regeneron
News
Novartis Takes Stake in Gamida with Option to Fully Buy
News
Gamida Cell Weighs Buyout; Novartis Mum on Report
Cancer
Gamida Cell Raises $10M to Progress Phase III-Stage Hematologic Cancer Cell Therapy
News
Cellerix to Test Gamida’s Expansion Technologies with Its Stem Cell-Based Drugs
News
Gamida Obtains Rights to Amgen Cytokines to Produce Stem Cell Cancer Drug
News
NovaThera and Gamida Cell Join Forces to Develop Cell Therapeutics for Lung Disease
Scroll Up